Weight-loss drug Belviq increases risk of cancer, FDA warns

Weight-loss drug Belviq increases risk of cancer, FDA warns

Weight-loss drug Belviq increases risk of cancer, FDA warns

The popular weight loss drug, called Belviq, also called Belviq XR (lorcaserin), has been found to increase the risk of developing cancer, warns the U.S. Food and Drug Administration (FDA).